[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:myeloproliferative-disorder":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":182,"states":187},"Myeloproliferative disorder",28,22,[8,16,23,29,35,42,48,54,60,66,72,78,84,90,96,101,107,113,119,125,131,137,143,150,156,162,168,175],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06303193","Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic\u002FMyeloproliferative Neoplasms",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:25.718160Z","2026-05-05T02:43:29.140075Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05442216","Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents",[20],"Phase 2","2026-08-26T02:16:13.426928Z","2026-07-19T19:36:05.118087Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT03850418","Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant",[20],"2026-08-26T02:18:02.701182Z","2026-05-29T15:36:40.172582Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06668584","A Phase II Open-label Study of Olutasidenib Post-transplant Maintenance Therapy for Patients With IDH1-mutated Myeloid Malignancies",[20],"2026-08-26T02:19:02.550788Z","2026-05-05T02:47:14.264276Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT03326310","Selumetinib and Azacitidine in High Risk Chronic Blood Cancers",[39],"Phase 1","2026-08-26T02:18:01.700186Z","2026-05-05T02:43:28.822764Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT07032727","Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations",[20],"2026-08-26T02:15:38.131683Z","2026-05-05T02:43:28.209956Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT03013998","Study of Biomarker-Based Treatment of Acute Myeloid Leukemia",[12],"2026-08-26T02:16:44.178623Z","2026-05-05T02:43:28.183972Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT06313593","A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms",[39],"2026-08-03T03:34:20.548203Z","2026-05-05T02:43:27.444739Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT07441694","Study of INCA036978 in Participants With Myeloproliferative Neoplasms",[39],"2026-08-26T02:16:20.336282Z","2026-05-05T02:43:27.275822Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT05320198","Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia",[12],"2026-08-26T02:18:53.782384Z","2026-07-24T01:27:14.872106Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT06315309","Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant",[20],"2026-08-26T02:16:48.735701Z","2026-05-05T02:43:29.662218Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT05554068","Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients",[20],"2026-08-26T02:18:37.277498Z","2026-05-05T02:43:29.020712Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT03314974","Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders",[20],"2026-08-26T02:16:14.341106Z","2026-05-05T02:43:28.206546Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT06291987","Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation",[39],"2026-08-26T02:15:21.365312Z","2026-05-05T02:43:27.513961Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":21,"content_modified":100},"NCT07214688","Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies",[20],"2026-05-05T02:43:27.479044Z",{"nct_id":102,"title":103,"phases":104,"status":13,"updated_at":105,"content_modified":106},"NCT02677064","Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia",[],"2026-08-26T02:18:00.873391Z","2026-07-30T01:46:14.456283Z",{"nct_id":108,"title":109,"phases":110,"status":13,"updated_at":111,"content_modified":112},"NCT07680868","Caris Chromoseq Data Collection",[],"2026-08-26T02:18:45.196599Z","2026-07-05T03:45:20.442609Z",{"nct_id":114,"title":115,"phases":116,"status":13,"updated_at":117,"content_modified":118},"NCT01137643","Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer",[],"2026-08-26T02:16:58.658552Z","2026-05-13T02:55:06.068895Z",{"nct_id":120,"title":121,"phases":122,"status":13,"updated_at":123,"content_modified":124},"NCT01137825","Registry of Older Patients With Cancer",[],"2026-08-26T02:16:16.169331Z","2026-05-13T02:55:06.068702Z",{"nct_id":126,"title":127,"phases":128,"status":13,"updated_at":129,"content_modified":130},"NCT07263074","Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories",[],"2026-08-26T02:17:22.153941Z","2026-07-19T19:36:05.066279Z",{"nct_id":132,"title":133,"phases":134,"status":13,"updated_at":135,"content_modified":136},"NCT04237623","GM-CSF With Post-Transplant Cyclophosphamide",[20],"2026-08-26T02:19:07.104270Z","2026-05-05T02:43:28.621208Z",{"nct_id":138,"title":139,"phases":140,"status":13,"updated_at":141,"content_modified":142},"NCT03245411","Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients",[],"2026-08-26T02:18:31.944757Z","2026-05-05T02:43:26.928781Z",{"nct_id":144,"title":145,"phases":146,"status":147,"updated_at":148,"content_modified":149},"NCT07549451","Phase 2 Study Of Imetelstat for Patient With Myelodysplastic\u002FMyeloproliferative Neoplasms",[20],"NOT_YET_RECRUITING","2026-08-26T02:16:17.877565Z","2026-05-05T02:43:27.307443Z",{"nct_id":151,"title":152,"phases":153,"status":147,"updated_at":154,"content_modified":155},"NCT07524530","Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers",[20],"2026-08-26T02:16:22.235886Z","2026-05-05T02:43:28.901767Z",{"nct_id":157,"title":158,"phases":159,"status":147,"updated_at":160,"content_modified":161},"NCT07710534","Metronomic Decitabine-Cedazuridine and Venetoclax in R\u002FR AML, HR-MDS, HR\u002FAP MPN",[20],"2026-08-26T02:18:29.369233Z","2026-07-19T19:36:05.094307Z",{"nct_id":163,"title":164,"phases":165,"status":147,"updated_at":166,"content_modified":167},"NCT07349134","WELL-MPN: A Digital Lifestyle App for Patients With MPNs",[],"2026-08-26T02:17:32.059863Z","2026-05-05T02:43:28.705774Z",{"nct_id":169,"title":170,"phases":171,"status":172,"updated_at":173,"content_modified":174},"NCT01728402","Pathogenesis of Hematologic Malignancies",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:54.876240Z","2026-06-16T05:54:07.945845Z",{"nct_id":176,"title":177,"phases":178,"status":179,"updated_at":180,"content_modified":181},"NCT05088356","Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w\u002FT-Cell Depleted Graft",[39],"ACTIVE_NOT_RECRUITING","2026-08-03T03:40:48.829801Z","2026-05-05T02:43:28.470053Z",[183],{"biomarker":184,"count":185,"slug":186},"IDH1 Gene",3,"idh1-gene",[188,192,195,199,202,206,209,212,216,219,222,225,228,231,234],{"state":189,"count":190,"slug":191},"New York",7,"new-york",{"state":193,"count":190,"slug":194},"Texas","texas",{"state":196,"count":197,"slug":198},"North Carolina",6,"north-carolina",{"state":200,"count":197,"slug":201},"Pennsylvania","pennsylvania",{"state":203,"count":204,"slug":205},"California",5,"california",{"state":207,"count":204,"slug":208},"Florida","florida",{"state":210,"count":204,"slug":211},"Illinois","illinois",{"state":213,"count":214,"slug":215},"Georgia",4,"georgia",{"state":217,"count":214,"slug":218},"Maryland","maryland",{"state":220,"count":214,"slug":221},"Oregon","oregon",{"state":223,"count":185,"slug":224},"Alabama","alabama",{"state":226,"count":185,"slug":227},"Arizona","arizona",{"state":229,"count":185,"slug":230},"Michigan","michigan",{"state":232,"count":185,"slug":233},"Minnesota","minnesota",{"state":235,"count":185,"slug":236},"Ohio","ohio"]